Pharmacological and Biological Circadian Therapy in Alzheimer’s Disease
Keywords:
MedicineDownloads
Download data is not yet available.
References
1. McCurry SM, Reynolds III CF, Ancoli-Israel S, Teri L et al. Treatment of sleep disturbance in Alzheimer’s Disease. Sleep Med Rev. 2000; 4: 603-628.
2. Zurad, E.G. New Treatments of Alzheimer Disease: A Review. Drug Benefit Trends 2000; 46: 246-260.
3. Wagner J, Wagner M. Non-benzodiazepines for the treatment of insomnia. Sleep Medicine Reviews 2000; 4: 551-581.
4. Fitzgerald MJT, Folan-Curran J. Clinical Neuroanatomy. 4th ed. Harcourt Publishers Limited, 2002.
5. Van Someren EJW. Circadian rhythms and sleep in human aging. Chronobiol Int. 2000; 17: 233-243.
6. Tatarelli R, Curti, E, Del Nero P. Diurinal sleep impairs cognitive performances in elderly: physiopathologic hypothesis. J Geriatric Psych Neuro. 1999; 12: 53-59.
7. Saper CB, Chou TC. The Sleep Switch: Hypothalamic control of sleep and wakefulness. Trends in Neurosciences 2001; 24: 726-735.
8. Vazquez J, Baghdoyan HA. Muscrinic and GABAA receptors modulate acetylcholine release in feline basal forebrain. Euro J Neurosciences. 2003; 17: 249-259.
9. Fernandez-Novoa L, Cacabelos R. Histamine in neurodegenerative disease. Behav Brain Res. 2001; 124: 213-233.
10. Hess CW. Sleep disorders and dementia. Schweiz Rundsch Med Prax 1997; 86: 1343-9.
11. McCarten JR, Kovera C, Maddox MK, Cleary JP. Triazolam in Alzheimer’s Disease: Pilot study on sleep and memory effects. Pharm Biochem and Behav. 1997; 52: 447-452.
12. Maurizi CP. Alzheimer’s Disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal flis deficency of melatonin. J Gerentology. 2001; 57: 156-160.
13. Skene DJ, Swaab DF. Melatonin rhythmicity: effect of age and Alzheimer’s disease. Exper Gerontology. 2003; 38: 199-206.
14. Jacobsen FM, Comas-Diaz L. Donepezil for psychotropic-induced memory loss. J Clin Psych. 1999; 60: 698-704.
15. Mishima K, Tozawa T, Satoh K, Matsumoto Y et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biolog Psych. 1999; 45: 417-421.
16. Monti JM, Cardinali DP. A critical assessment of the melatonin effect on sleep in humans. Biol Signals Recept. 2000; 9: 328-39.
17. Yamadera H, Ito T, Suzuki H, Asayama K. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psych Clin Neurosciences. 2000; 54: 352-353.
18. Ito T, Yamadera H, Ito R, Suzuki H et al. Effects of vitamin B12 on bright light on cognitive and sleep- wake rhythm in Alzheimer-type dementia. Psych Clin Neurosciences. 2000; 55: 281-282.
2. Zurad, E.G. New Treatments of Alzheimer Disease: A Review. Drug Benefit Trends 2000; 46: 246-260.
3. Wagner J, Wagner M. Non-benzodiazepines for the treatment of insomnia. Sleep Medicine Reviews 2000; 4: 551-581.
4. Fitzgerald MJT, Folan-Curran J. Clinical Neuroanatomy. 4th ed. Harcourt Publishers Limited, 2002.
5. Van Someren EJW. Circadian rhythms and sleep in human aging. Chronobiol Int. 2000; 17: 233-243.
6. Tatarelli R, Curti, E, Del Nero P. Diurinal sleep impairs cognitive performances in elderly: physiopathologic hypothesis. J Geriatric Psych Neuro. 1999; 12: 53-59.
7. Saper CB, Chou TC. The Sleep Switch: Hypothalamic control of sleep and wakefulness. Trends in Neurosciences 2001; 24: 726-735.
8. Vazquez J, Baghdoyan HA. Muscrinic and GABAA receptors modulate acetylcholine release in feline basal forebrain. Euro J Neurosciences. 2003; 17: 249-259.
9. Fernandez-Novoa L, Cacabelos R. Histamine in neurodegenerative disease. Behav Brain Res. 2001; 124: 213-233.
10. Hess CW. Sleep disorders and dementia. Schweiz Rundsch Med Prax 1997; 86: 1343-9.
11. McCarten JR, Kovera C, Maddox MK, Cleary JP. Triazolam in Alzheimer’s Disease: Pilot study on sleep and memory effects. Pharm Biochem and Behav. 1997; 52: 447-452.
12. Maurizi CP. Alzheimer’s Disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal flis deficency of melatonin. J Gerentology. 2001; 57: 156-160.
13. Skene DJ, Swaab DF. Melatonin rhythmicity: effect of age and Alzheimer’s disease. Exper Gerontology. 2003; 38: 199-206.
14. Jacobsen FM, Comas-Diaz L. Donepezil for psychotropic-induced memory loss. J Clin Psych. 1999; 60: 698-704.
15. Mishima K, Tozawa T, Satoh K, Matsumoto Y et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biolog Psych. 1999; 45: 417-421.
16. Monti JM, Cardinali DP. A critical assessment of the melatonin effect on sleep in humans. Biol Signals Recept. 2000; 9: 328-39.
17. Yamadera H, Ito T, Suzuki H, Asayama K. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psych Clin Neurosciences. 2000; 54: 352-353.
18. Ito T, Yamadera H, Ito R, Suzuki H et al. Effects of vitamin B12 on bright light on cognitive and sleep- wake rhythm in Alzheimer-type dementia. Psych Clin Neurosciences. 2000; 55: 281-282.
Downloads
Published
2004-01-01
How to Cite
Greaney, D. (2004). Pharmacological and Biological Circadian Therapy in Alzheimer’s Disease. Trinity Student Medical Journal , 5(1), Page 55–60. Retrieved from https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/1943
Issue
Section
Reviews
License
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.
